Denali Therapeutics Inc
NASDAQ · DNLI
Fundamentals
Market cap
$3.65B
Price / Earnings ratio
-7.6x
Price / Sales ratio
N/A
Price / Book ratio
4.2x
Return on assets
-0.4%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A


